Cargando…
Influence of dosing times on cisplatin-induced peripheral neuropathy in rats
BACKGROUND: Although cis-diamminedichloro-platinum (CDDP) exhibits strong therapeutic effects in cancer chemotherapy, its adverse effects such as peripheral neuropathy, nephropathy, and vomiting are dose-limiting factors. Previous studies reported that chronotherapy decreased CDDP-induced nephropath...
Autores principales: | Seto, Yoshihiro, Okazaki, Fumiyasu, Horikawa, Keiji, Zhang, Jing, Sasaki, Hitoshi, To, Hideto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5039788/ https://www.ncbi.nlm.nih.gov/pubmed/27678475 http://dx.doi.org/10.1186/s12885-016-2777-0 |
Ejemplares similares
-
Effects of a rifampicin pre-treatment on linezolid pharmacokinetics
por: Okazaki, Fumiyasu, et al.
Publicado: (2019) -
Peripheral neuropathy induced by combination chemotherapy of docetaxel and cisplatin.
por: Hilkens, P. H., et al.
Publicado: (1997) -
Targeting Oxidative Stress, Autophagy, and Apoptosis by Quercetin to Ameliorate Cisplatin-induced Peripheral Neuropathy in Rats
por: Mahmoud, Heba A., et al.
Publicado: (2023) -
Cannabinoids and agmatine as potential therapeutic alternatives for cisplatin-induced peripheral neuropathy
por: Donertas, Basak, et al.
Publicado: (2018) -
Prevalence and Predictors of Cisplatin-Induced Peripheral Neuropathy at the Kenyatta National Hospital
por: Ezzi, Mohammed S., et al.
Publicado: (2019)